succinobucol has been researched along with Arteriosclerosis in 8 studies
*Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hill, RR; Holt, LA; Hoong, LK; Kunsch, C; Meng, CQ; Olliff, LK; Parthasarathy, S; Rachita, CL; Saxena, U; Sikorski, JA; Simpson, JE; Somers, PK; Sundell, CL; Wasserman, MA; Zheng, XS | 1 |
| Bourassa, MG; Glass, M; Grégoire, J; Guertin, MC; L'Allier, PL; Lambert, J; Laramée, L; Lespérance, J; Reeves, F; Schwartz, L; Tardif, JC; Title, L | 1 |
| Alexander, RW; Butteiger, D; Chapman, A; Daugherty, A; Edwards, D; Hill, RR; Hoong, LK; Jones, M; Landers, LK; Medford, RM; Meng, CQ; Saxena, U; Somers, PK; Suen, KL; Sundell, CL; Wasserman, MA | 1 |
| Edwards, D; Kunsch, C; Medford, RM; Meng, CQ; Sundell, CL; Wasserman, MA | 1 |
| Tardif, JC | 2 |
| Stix, G | 1 |
| Doggrell, SA | 1 |
4 review(s) available for succinobucol and Arteriosclerosis
| Article | Year |
|---|---|
Chemistry and pharmacology of vascular protectants: a novel approach to the treatment of atherosclerosis and coronary artery disease.
Topics: Antioxidants; Arteriosclerosis; Cardiovascular System; Coronary Artery Disease; Humans; Probucol; Signal Transduction | 2003 |
Clinical results with AGI-1067: a novel antioxidant vascular protectant.
Topics: Antioxidants; Arteriosclerosis; Clinical Trials as Topic; Humans; Oxidative Stress; Probucol | 2003 |
Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growth.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Clinical Trials as Topic; Coronary Restenosis; Disease Models, Animal; Endothelium, Vascular; Humans; Probucol | 2003 |
Antioxidants and atherosclerosis: emerging drug therapies.
Topics: Antioxidants; Arteriosclerosis; Clinical Trials as Topic; Coronary Restenosis; Humans; Oxidative Stress; Probucol | 2005 |
1 trial(s) available for succinobucol and Arteriosclerosis
| Article | Year |
|---|---|
Effects of AGI-1067 and probucol after percutaneous coronary interventions.
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Coronary Disease; Coronary Restenosis; Coronary Vessels; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Probucol; Stents; Treatment Outcome; Ultrasonography, Interventional; Vascular Patency | 2003 |
3 other study(ies) available for succinobucol and Arteriosclerosis
| Article | Year |
|---|---|
Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis.
Topics: Animals; Antioxidants; Arteriosclerosis; Humans; Phenols; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2002 |
AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent.
Topics: Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Disease Models, Animal; Endothelium, Vascular; Humans; Lipid Metabolism; Macaca fascicularis; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Probucol | 2003 |
Signal jammer. An academic experiment leads to a new class of drug for attacking heart disease.
Topics: Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Clinical Trials as Topic; Drug Industry; Heart Diseases; Humans; Probucol | 2003 |